119
234. Webster, K. A. (2006). Puma joins the battery of BH3-only proteins that promote death
and infarction during myocardial ischemia. American Journal of Physiology. Heart and
Circulatory Physiology, 291(1), H20–H22.
235. Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Bohm, M., et al. (2003). Intravenous
transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.
Circulation Research, 93(2), e17–e24.
236. Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., et
al. (2006). Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding
domain: Enhancement of VEGF biological activity by a singular growth factor/matrix protein
synergism. Circulation Research, 99(8), 853–860.
237. Williams, S. E., Wootton, P., Mason, H. S., Bould, J., Iles, D. E., Riccardi, D., et al. (2004).
Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science,
306(5704), 2093–2097.
238. Wolburg, H., & Lippoldt, A. (2002). Tight junctions of the blood-brain barrier: Development,
composition and regulation. Vascular Pharmacology, 38(6), 323–337.
239. Wolin, M. S., Ahmad, M., & Gupte, S. A. (2005). Oxidant and redox signaling in vascular
oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. American Journal of Physiology. Lung Cellular and Molecular
Physiology, 289(2), L159–L173.
240. Xu, W., Koeck, T., Lara, A. R., Neumann, D., DiFilippo, F. P., Koo, M., et al. (2007).
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proceedings of the
National Academy of Sciences of the United States of America, 104(4), 1342–1347.
241. Yamakawa, M., Liu, L. X., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., et al. (2003).
Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by
inducing multiple angiogenic factors. Circulation Research, 93(7), 664–673.
242. Yoon, C. H., Hur, J., Oh, I. Y., Park, K. W., Kim, T. Y., Shin, J. H., et al. (2006). Intercellular
adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of
endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(5),
1066–1072.
243. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., & Yamanaka, S. (2009). Hypoxia enhances
the generation of induced pluripotent stem cells. Cell Stem Cell, 5(3), 237–241.
244. Yung, C. W., Wu, L. Q., Tullman, J. A., Payne, G. F., Bentley, W. E., & Barbari, T. A. (2007).
Transglutaminase crosslinked gelatin as a tissue engineering scaffold. Journal of Biomedical
Materials Research Part A, 83A(4), 1039–1046.
245. Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., et al.
(2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to
hypoxia. The Journal of Biological Chemistry, 283(16), 10892–10903.
246. Zhang, X., Liu, L., Wei, X., Tan, Y. S., Tong, L., Chang Bs, R., et al. (2010). Impaired
angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygousnull mice after burn wounding. Wound Repair and Regeneration, 18, 193–201.
247. Zhou, X., Rowe, R. G., Hiraoka, N., George, J. P., Wirtz, D., Mosher, D. F., et al. (2008).
Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes and
Development, 22(9), 1231–1243.
248. Zisch, A. H., Lutolf, M. P., & Hubbell, J. A. (2003). Biopolymeric delivery matrices for
angiogenic growth factors. Cardiovascular Pathology, 12(6), 295–310.
249. Zisch, A. H., Lutolf, M. P., Ehrbar, M., Raeber, G. P., Rizzi, S. C., Davies, N., et al. (2003).
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for
vascularized tissue growth. The FASEB Journal, 17(15), 2260–2262.
4 Hypoxia and Matrix Manipulation for Vascular Engineering
234. Webster, K. A. (2006). Puma joins the battery of BH3-only proteins that promote death
and infarction during myocardial ischemia. American Journal of Physiology. Heart and
Circulatory Physiology, 291(1), H20–H22.
235. Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Bohm, M., et al. (2003). Intravenous
transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.
Circulation Research, 93(2), e17–e24.
236. Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., et
al. (2006). Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding
domain: Enhancement of VEGF biological activity by a singular growth factor/matrix protein
synergism. Circulation Research, 99(8), 853–860.
237. Williams, S. E., Wootton, P., Mason, H. S., Bould, J., Iles, D. E., Riccardi, D., et al. (2004).
Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science,
306(5704), 2093–2097.
238. Wolburg, H., & Lippoldt, A. (2002). Tight junctions of the blood-brain barrier: Development,
composition and regulation. Vascular Pharmacology, 38(6), 323–337.
239. Wolin, M. S., Ahmad, M., & Gupte, S. A. (2005). Oxidant and redox signaling in vascular
oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. American Journal of Physiology. Lung Cellular and Molecular
Physiology, 289(2), L159–L173.
240. Xu, W., Koeck, T., Lara, A. R., Neumann, D., DiFilippo, F. P., Koo, M., et al. (2007).
Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proceedings of the
National Academy of Sciences of the United States of America, 104(4), 1342–1347.
241. Yamakawa, M., Liu, L. X., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., et al. (2003).
Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by
inducing multiple angiogenic factors. Circulation Research, 93(7), 664–673.
242. Yoon, C. H., Hur, J., Oh, I. Y., Park, K. W., Kim, T. Y., Shin, J. H., et al. (2006). Intercellular
adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of
endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(5),
1066–1072.
243. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., & Yamanaka, S. (2009). Hypoxia enhances
the generation of induced pluripotent stem cells. Cell Stem Cell, 5(3), 237–241.
244. Yung, C. W., Wu, L. Q., Tullman, J. A., Payne, G. F., Bentley, W. E., & Barbari, T. A. (2007).
Transglutaminase crosslinked gelatin as a tissue engineering scaffold. Journal of Biomedical
Materials Research Part A, 83A(4), 1039–1046.
245. Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., et al.
(2008). Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to
hypoxia. The Journal of Biological Chemistry, 283(16), 10892–10903.
246. Zhang, X., Liu, L., Wei, X., Tan, Y. S., Tong, L., Chang Bs, R., et al. (2010). Impaired
angiogenesis and mobilization of circulating angiogenic cells in HIF-1alpha heterozygousnull mice after burn wounding. Wound Repair and Regeneration, 18, 193–201.
247. Zhou, X., Rowe, R. G., Hiraoka, N., George, J. P., Wirtz, D., Mosher, D. F., et al. (2008).
Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes and
Development, 22(9), 1231–1243.
248. Zisch, A. H., Lutolf, M. P., & Hubbell, J. A. (2003). Biopolymeric delivery matrices for
angiogenic growth factors. Cardiovascular Pathology, 12(6), 295–310.
249. Zisch, A. H., Lutolf, M. P., Ehrbar, M., Raeber, G. P., Rizzi, S. C., Davies, N., et al. (2003).
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for
vascularized tissue growth. The FASEB Journal, 17(15), 2260–2262.
4 Hypoxia and Matrix Manipulation for Vascular Engineering